Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does BOPO qualify to double down into yet?
Thanks
Does it have to close at .10 or above?
Thanks
Somebody, some intuition, definitely seems to know
something BIG is about to happen here.
TGLO
Somebody knows something.
Definitely.
TGLO getting frisky.
On July 5, 2023, Digital Locations, Inc. (the “Company”) filed a Certificate of Designation to its Articles of Incorporation (the “Certificate”) designating a new class of “Series F Preferred Stock.” The filing of the Certificate was authorized and approved by the Company’s Board of Directors. The Certificate designates 10,000 shares of Series F Preferred Stock, with a stated face value of $100 per share and the right of conversion by the holder at any time into shares of the Company’s Common Stock at a conversion price of $0.0007 per share.
Surprised we have not seen a
volume surge upward
with this update.
Borders is not going to loose $$ here.
He will buy it up to the next level.
IMHO
Looks like we are just about ready here.
Longer it moves sideways, the bigger the surge upwards.
https://stockcharts.com/h-sc/ui?s=MONI
That is some very good reasoning.
People think about it. What would happen?
With another buying spree.
B o o m
Picked up some .085's on the last trade.
First time adding in a very long time.
Cannot add like we did this morning for the past couple of hours.
Selling seems to have dried up for now.
Unless you hit that Ask.
Added this morning about 3 different times.
Order in now too.... Lower
Unfortunately How Low are we going to go?
MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access
July 06 2023 - 09:38AM
InvestorsHub NewsWire
MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and
Altcoins for Drug Discovery, Revolutionizing Investment Access
CAPE TOWN, SOUTH AFRICA -- July 6, 2023 -- InvestorsHub NewsWire -- Institute of Biomedical Research Corp. (OTC PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, is pleased to share the following update:
M2Bio Sciences, a pioneering biotech company at the forefront of drug discovery, proudly announces the release of an informative explainer video elucidating their recent press release regarding the creation of NFTs and Altcoins for Drug Discovery. This revolutionary development is set to democratize investing in drug discovery by offering unprecedented access to potential investors.
The captivating explainer video, now available on M2Bio Sciences' official website and various social media platforms, provides a comprehensive overview of the groundbreaking concept introduced in their earlier press release dated June 27th, 2023. Through the implementation of non-fungible tokens (NFTs) and alternative coins (Altcoins), M2Bio Sciences aims to transform the way individuals participate in and benefit from drug discovery investments.
The explainer video dives deep into the core principles of M2Bio Sciences' initiative. By tokenizing drug discovery assets and creating NFTs, M2Bio Sciences introduces an innovative investment opportunity that enables individuals from diverse backgrounds to contribute and partake in the future of healthcare breakthroughs. Moreover, the introduction of Altcoins within this ecosystem will empower investors to engage in a decentralized marketplace that further amplifies the potential for growth and collaboration.
"We are thrilled to unveil this explainer video, which aims to educate and inspire individuals about our novel approach to democratizing investing in drug discovery," said Jeff Robinson, CEO of M2Bio Sciences. "Our vision is to remove barriers and provide everyone with the opportunity to play an active role in the development of life-changing pharmaceuticals. By leveraging NFTs and Altcoins, we are creating a more inclusive and accessible ecosystem for investors worldwide."
The explainer video highlights the key advantages of M2Bio Sciences' pioneering solution. It emphasizes the transparency, security, and liquidity brought forth by blockchain technology, which ensures seamless and trustworthy transactions within the drug dM2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFT and Altcoins for Drug Discovery investment landscape. Furthermore, the integration of Altcoins fosters a global community of investors, researchers, and pharmaceutical professionals, collectively working towards transformative healthcare advancements.
By demystifying the complex concepts behind NFTs, Altcoins, and their application in drug discovery, the video ensures that viewers gain a comprehensive understanding of this groundbreaking investment opportunity. It showcases M2Bio Sciences' commitment to driving meaningful change and promoting financial inclusivity within the pharmaceutical industry.
To view the explainer video and learn more about M2Bio Sciences' revolutionary NFTs and Altcoins for Drug Discovery, please visit the M2Bio Sciences YouTube channel found here.
M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFT and Altcoins for Drug Discovery
M2Bio Sciences is a pioneering biotech company dedicated to revolutionizing drug discovery through innovative solutions and technological advancements. By combining cutting-edge research, blockchain technology, and decentralized finance, M2Bio Sciences is empowering individuals globally to participate in the democratization of drug discovery investment. With a relentless pursuit of scientific excellence, M2Bio Sciences aims to create transformative pharmaceuticals and improve healthcare outcomes for communities worldwide.
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp, is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, Liviana™ brands as well as artificial intelligence powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES".
Can we get current now?
A must read from Mr. Stervc
I have not kept up lately .
Borders LLC looking to soak up the float bigley
It seems to me that they "borders" have disappeared.
Any updates?
Good stuff.
A must read DD
Yep, I say it every time
Why didn't I buy more.
Been holding a long time.
The gang is all here.
Reunion party about to begin.
Quote from an earlier post.
Bottom line, how does carnes or any insider of Apsi benefit if they go expert market and stay there? They don’t, so it’s just a question of how long I have to wait. Imo
Agree I am in the same camp.
Fantastic thanks for the real time update.
I like your price quotes.
Very helpful when a person is not sitting behind a computer
I have not sold any shares .
I sure hope you / we are right.
You could be saying that more that once.
So everybody, investors, management, employees family's, loose everything $$$, except the lawyers and auditors who got paid already.
I don't understand why a company would spend $50,000 to hundreds of thousands of dollars to end here.?
Unfathomable to explode and be gone.
Just crazy .
Absolutely stupidity.
Congrats on the Buy
Pretty smart having the cash on hank.
I am not so smart.
Ug.
Good morning.
MONI seems to be on a roll.
Just might be time to add a few more here.
Things are lining up day after day.
Agree. Just got to get past all these sellers
That most likely have been in MRES for a very long time.
They see it as a time to unload their position and move on.
New blood and the new Hope needed here.
Buyers see the future with MRES.
Bid moving up in Pre-market.
Might be interesting today.
Moni # 9 most read board now.
All Very Nice.
Thanks.
Cannot be much left here @ .023.
Back down to .023.
MONI moving up now.
Ok then....We just might be looking good here.
Thank You for your input here. Mr Stervc
Large 800k Bid flashed for a second ,
Its in there somewhere.
Agree.